Stock Market Reviews

ACXP (Acurx Pharmaceuticals, Inc.) News

Get the latest news, insights, and market updates on ACXP (Acurx Pharmaceuticals, Inc.). Explore the news page 2 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• Acurx Announces New Data on its DNA pol IIIC Inhibitor Antibiotics Demonstrating a Potential Class Effect of Gut Microbiome Selectivity Presented at IDWeek 2025 Scientific Conference
  Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), is a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections. It announced today that a presentation was given by Michael Silverman, MD, FACP, Acurx's Medical Director, and Kevin Garey, PharmD, MS, FIDSA, Professor and Chair, University of Houston College of Pharmacy, Principal Investigator for microbiology and microbiome aspects of the ibezapolstat clinical trial
  Oct 28, 2025 - $ACXP
• Acurx Pharmaceuticals to Discuss Third Quarter 2025 Financial Results on November 12, 2025 Conference Call and Provide Business Update
  Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today that the Company will discuss its third quarter 2025 financial results on Wednesday, November 12, 2025 at 8:00 am ET before the U.S. financial markets open.
  Oct 27, 2025 - $ACXP
• New to The Street to Broadcast Nationwide on Bloomberg TV Tonight at 6:30 PM EST Featuring Roadzen, Spartan Equipment, XION, Metaterra, and YY Group
  The show broadcasts as sponsored programming with featured commercials by Laser Photonics (NASDAQ:LASE), PetVivo (OTCQB:PETV), Aeries Technology (NASDAQ:AERT), Acurx Pharmaceuticals (NASDAQ:ACXP), and DataVault Holdings (NASDAQ:DVLT). NEW YORK CITY, ...
  Oct 25, 2025 - $ACXP
• New to The Street Show #694 to Broadcast Tonight at 6:30 PM EST as Sponsored Programming on Bloomberg TV Featuring Stardust Power (NASDAQ:SDST), Spartan Equipment, Roadzen (NASDAQ:RDZN), Aeries Technology (NASDAQ:AERT), and XION
  NEW YORK CITY, NY / ACCESS Newswire / October 18, 2025 /New to The Street, one of the nation's longest-running business television brands airing as sponsored programming on Bloomberg Television (6:30 PM EST) and Fox Business, announces the broadcast ...
  Oct 18, 2025 - $ACXP
• New to The Street Broadcasts Tonight on Bloomberg Featuring Roadzen, Metaterra, NRx Pharma, Blackbarn NYC, and Humanitarian Travel Group
  The show is sponsored programming with commercials featuring LASE Technologies ($LASE), PetVivo ($PETV), Acurx Pharmaceuticals ($ACXP), Synergy CHC ($SNYR), and NewsOut - the video press release company. NEW YORK CITY, NY / ACCESS Newswire / October ...
  Oct 11, 2025 - $ACXP
• Meet the Companies - New to The Street's Accredited Investor Event Returns October 21-22 at Hudson Yards, NYC
  NEW YORK CITY, NEW YORK / ACCESS Newswire / October 10, 2025 /New to The Street, one of the nation's longest-running business television brands airing as sponsored programming on Fox Business and Bloomberg, announces its upcoming "Meet the Companies" ...
  Oct 10, 2025 - $ACXP
• Australian Patent Office Grants Acurx Patent for DNA Polymerase IIIC Inhibitors
  Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial infections, today announced that a new patent has been granted by the Australian Patent Office. This patent relates to DNA Polymerase IIIC Inhibitors, including compositions-of- matter. This is the latest in the series of granted patents and pending patent applications that Acurx has filed to protect it
  Oct 9, 2025 - $ACXP
• New to The Street to Broadcast Tonight on Fox Business 10:30 PM PST Featuring NeOnc Technologies, FLOKI, XION, Sharps Technology, and Aeries Technology
  NEW YORK CITY, NEW YORK / ACCESS Newswire / October 6, 2025 /New to The Street, one of America's longest-running business television brands, announces tonight's nationwide broadcast on Fox Business at 10:30 PM PST. The episode features exclusive interviews ...
  Oct 7, 2025 - $ACXP
• New to The Street to Broadcast Nationwide on Bloomberg Tonight at 6:30 PM EST
  Sponsored Programming Featuring Commercials by Laser Photonics Corp. (NASDAQ:LASE), Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP), PetVivo Holdings, Inc. (NASDAQ:PETV), DataVault AI (NASDAQ:DVLT), and The Sustainable Green Team (OTCQX:SGTM) NEW YORK CITY, ...
  Oct 4, 2025 - $ACXP
• Acurx Announces Positive Opinion from EMA on Pediatric Investigation Plan for Ibezapolstat Use in Children with C. difficile Infection
  Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company") is a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial infections announced receipt of a favorable opinion from the PDCO of the EMA on Acurx's Pediatric Investigation Plan (PIP) for ibezapolstat use in children with C. difficile infection (CDI).
  Sep 30, 2025 - $ACXP